+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Allergic Conjunctivitis Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis

  • PDF Icon

    Report

  • 195 Pages
  • February 2022
  • Region: Global
  • Renub Research
  • ID: 5546198
Allergic Conjunctivitis Market is expected to reach US$ 1,642.6 Million by 2027. Allergic conjunctivitis interchangeably is also known as Ocular allergy (OA). It is a common immunological hypersensitivity disorder affecting numerous populations. In recent years, allergic conjunctivitis has been increasing in frequency, with symptoms of itching, redness, and swelling globally that significantly impact an individual’s quality of life. Besides, allergic conjunctivitis is an often under diagnosed and undertreated health problem because very few patients with allergic conjunctivitis symptoms seek medical attention, whereas most patients manage with over-the-counter medications and complementary no pharmacological remedies.



Global Allergic Conjunctivitis Market Size was US$ 1,621.5 Million in 2021


Recently, the prevalence of allergic conjunctivitis has increased due to factors like rapid urbanization and an increasing number of allergens. Moreover, increasing awareness is further expected to boost the adoption of drugs for allergic conjunctivitis conditions during the forecast period. Remarkably, considering these contributively factors, a substantial influx of generic versions of prominent medications is likely to create growth opportunities for the global allergic conjunctivitis market during the forecast period. Furthermore, increasing prescription (Rx) drugs to over-the-counter (OTC) switches are also expected to boost this market.

United States dominates Global Allergic Conjunctivitis Market, Patients Population & Treated Patients Population


As per our analysis, the United States stands out as the largest market for allergic conjunctivitis treatments due to the high prevalence of allergic conjunctivitis. Further, the allergic conjunctivitis treatment market in the United States has the most dominant patient population and is also expected to have a large population base in the forecasted period. Remarkably, leading to increased demand for improved health care facilities, the country also has the most significant treated patients’ population.

Further, rapid urbanization and increased particulate pollution have augmented the incidence of allergic conjunctivitis in several countries, such as India and China. However, a few factors such as a dearth of awareness among the general public concerning eye disorders and lack of health insurance control the market in France, Germany, Italy, and Spain. According to the publisher, Global Allergic Conjunctivitis Industry has grown with a CAGR of 0.2% from 2021-2027.

Impact of Coronavirus (COVID-19) Pandemic on Global Allergic Conjunctivitis Market


COVID-19 virus outbreak in December 2019 had spread to over 100 countries across the globe. Moreover, COVID-19 affected the economy in three significant ways; by directly affecting production and demand, devising disruptions in distribution channels, and its financial influence on firms and financial markets. Further, players operating in the worldwide allergic conjunctivitis industry faced significant challenges on various fronts due to the COVID-19 pandemic.

Nevertheless, significant challenges comprise the supply of raw materials required for drug formulations due to irregularities in transportation. Moreover, distributors also experienced irregular demand for products from the retailers due to the increased number of patients suffering from COVID-19 and other life-threatening disorders.

Allergic Conjunctivitis Associated with Medical Treatment & Upcoming Therapies Are Enhancing the Market Expansion


Our report covers numerous Disease Type variants like Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC), and Giant Papillary Conjunctivitis (GPC). Moreover, in our report, we have also covered, Allergic Conjunctivitis Pipeline Drugs like Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011. The increase in awareness of allergic conjunctivitis associated with medical treatment & upcoming therapies is enhancing the market expansion. Moreover, numerous pharmaceutical companies are trying to develop many new treatment possibilities for allergic conjunctivitis.

Key Market Players


Major players performing in the global allergic conjunctivitis market are Ocular Therapeutix Inc., Portola Pharmaceuticals Inc., Alcon, Santen Pharmaceutical Co., Ltd., and Novartis. Key players operating in the market are tremendously focusing on developing treatments for allergic conjunctivitis. This is anticipated to drive the global allergic conjunctivitis market growth during the forecast period.

Further, the market players are considerably contributing to market growth by adopting various strategies, including new product launches, mergers and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market.

This research report titled “Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Kerato Conjunctivitis (VKC), Atopic Kerato Conjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Ocular Therapeutix Inc., Portola Pharmaceuticals Inc., Alcon, Santen Pharmaceutical Co., Ltd., and Novartis)” provides a detailed analysis of Allergic Conjunctivitis Industry.

Country - Market, Patient Numbers and Treated Patient Numbers breakup from 9 viewpoints:


  • India
  • China
  • Japan
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain

Disease - Market Breakup from 4 viewpoints:


  • Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • Vernal Kerato Conjunctivitis (VKC)
  • Atopic Kerato Conjunctivitis (AKC)
  • Giant Papillary Conjunctivitis (GPC)

Drugs - Market Breakup from 10 viewpoints:


  • Zerviate
  • OTX-DP
  • ADX-102
  • PRT-2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

Company Insights:


  • Overviews
  • Recent Developments
  • Revenues

Companies Covered:


  • Ocular Therapeutix Inc.
  • Portola Pharmaceuticals Inc.
  • Alcon
  • Santen Pharmaceutical Co., Ltd.
  • Novartis

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Allergic Conjunctivitis Market and Patients Analysis
5.1 Market
5.2 Patient Numbers
5.3 Treated Patient Numbers
6. Share Analysis - Global Allergic Conjunctivitis
6.1 Country Market Share
6.2 Patients Population Share
6.3 Treated Patients Population Share
6.4 By Disease Type Share
7. India - Allergic Conjunctivitis Analysis
7.1 Market
7.2 Patient Numbers
7.3 Treated Patient Numbers
8. China - Allergic Conjunctivitis Analysis
8.1 Market
8.2 Patient Numbers
8.3 Treated Patient Numbers
9. Japan - Allergic Conjunctivitis Analysis
9.1 Market
9.2 Patient Numbers
9.3 Treated Patient Numbers
10. United States - Allergic Conjunctivitis Analysis
10.1 Market
10.2 Patient Numbers
10.3 Treated Patient Numbers
11. United Kingdom - Allergic Conjunctivitis Analysis
11.1 Market
11.2 Patient Numbers
11.3 Treated Patient Numbers
12. France - Allergic Conjunctivitis Analysis
12.1 Market
12.2 Patient Numbers
12.3 Treated Patient Numbers
13. Germany - Allergic Conjunctivitis Analysis
13.1 Market
13.2 Patient Numbers
13.3 Treated Patient Numbers
14. Italy - Allergic Conjunctivitis Analysis
14.1 Market
14.2 Patient Numbers
14.3 Treated Patient Numbers
15. Spain - Allergic Conjunctivitis Analysis
15.1 Market
15.2 Patient Numbers
15.3 Treated Patient Numbers
16. Disease Type - Global Allergic Conjunctivitis Market
16.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC
16.2 Vernal Keratoconjunctivitis (VKC)
16.3 Atopic Keratoconjunctivitis (AKC)
16.4 Giant Papillary Conjunctivitis (GPC)
17. Global Allergic Conjunctivitis Pipeline Drugs
17.1 Zerviate
17.2 OTX-DP (Dexamethasone Insert)
17.3 ADX-102
17.4 PRT2761
17.5 CVXL-0074
17.6 AK-002
17.7 Bertilimumab
17.8 Reproxalap
17.9 ST-266
17.10 SYL-116011
18. Porters Five Forces
18.1 Overview
18.2 Bargaining Power of Buyers
18.3 Bargaining Power of Suppliers
18.4 Degree of Competition
18.5 Threat of New Entrants
18.6 Threat of Substitutes
19. Company Analysis
19.1 Ocular Therapeutix Inc.
19.1.1 Overview
19.1.2 Recent Development
19.1.3 Revenue
19.2 Portola Pharmaceuticals Inc.
19.2.1 Overview
19.2.2 Recent Development
19.2.3 Revenue
19.3 Alcon
19.3.1 Overvie
19.3.2 Recent Development
19.3.3 Revenue
19.4 Santen Pharmaceutical Co., Ltd.
19.4.1 Overview
19.4.2 Recent Development
19.4.3 Revenue
19.5 Novartis
19.5.1 Overview
19.5.2 Recent Developmen
19.5.3 Revenue
List of Figures
Figure 01: Global - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 02: Global - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 03: Global - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 04: Global - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 05: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 06: Global - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 07: India - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 08: India - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 09: India - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 10: India - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 11: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 12: India - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 13: China - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 14: China - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 15: China - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 16: China - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 17: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 18: China - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 19: Japan - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 20: Japan - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 21: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 22: Japan - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 23: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 24: Japan - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 25: United States - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 26: United States - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 27: United States - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 28: United States - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 29: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 30: United States - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 31: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 32: United Kingdom - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 33: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 34: United Kingdom - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 35: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 36: United Kingdom - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 37: France - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 38: France - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 39: France - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 40: France - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 41: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 42: France - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 43: Germany - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 44: Germany - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 45: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 46: Germany - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 47: Germany - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 48: Germany - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 49: Italy - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 50: Italy - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 51: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 52: Italy - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 53: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 54: Italy - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 55: Spain - Allergic Conjunctivitis Market (Million US$), 2016 - 2021
Figure 56: Spain - Forecast for Allergic Conjunctivitis Market (Million US$), 2022 - 2027
Figure 57: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2021
Figure 58: Spain - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2022 - 2027
Figure 59: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2021
Figure 60: Spain - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2022 - 2027
Figure 61: Disease Type - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2016 - 2021
Figure 62: Disease Type - Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2022 - 2027
Figure 63: Disease Type - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2016 - 2021
Figure 64: Disease Type - Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2022 - 2027
Figure 65: Disease Type - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2016 - 2021
Figure 66: Disease Type - Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2022 - 2027
Figure 67: Disease Type - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2016 - 2021
Figure 68: Disease Type - Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2022 - 2027
Figure 69: Ocular Therapeutix Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 70: Ocular Therapeutix Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 71: Portola Pharmaceuticals Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 72: Portola Pharmaceuticals Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 73: Alcon - Global Revenue (Million US$), 2016 - 2021
Figure 74: Alcon - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 75: Santen Pharmaceutical Co., Ltd. - Global Revenue (Million US$), 2016 - 2021
Figure 76: Santen Pharmaceutical Co., Ltd. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 77: Novartis - Global Revenue (Million US$), 2016 - 2021
Figure 78: Novartis - Forecast for Global Revenue (Million US$), 2022 - 2027
List of Tables
Table 01: Global - Allergic Conjunctivitis Market Share by Countries (Percent), 2018 - 2021
Table 02: Global - Forecast for Allergic Conjunctivitis Market Share by Countries (Percent), 2022 - 2027
Table 03: Global - Allergic Conjunctivitis Patients Population Share by Countries (Percent), 2018 - 2021
Table 04: Global - Forecast for Allergic Conjunctivitis Patients Population Share by Countries (Percent), 2022 - 2027
Table 05: Global - Allergic Conjunctivitis Treated Patients Population Share by Countries (Percent), 2018 - 2021
Table 06: Global - Forecast for Allergic Conjunctivitis Treated Patients Population Share by Countries (Percent), 2022 - 2027
Table 07: Global - Allergic Conjunctivitis Market Share by Disease Type (Percent), 2018 - 2021
Table 08: Global - Forecast for Allergic Conjunctivitis Market Share by Disease Type (Percent), 2022 - 2027

Companies Mentioned

  • Ocular Therapeutix Inc.
  • Portola Pharmaceuticals Inc.
  • Alcon
  • Santen Pharmaceutical Co., Ltd.
  • Novartis

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information